CARsgen Therapeutics Holdings Ltd

1
HKSE:02171 (China)   Ordinary Shares
HK$ 6.10 (-0.97%) May 16
At Loss
P/B:
1.78
Market Cap:
HK$ 3.51B ($ 449.93M)
Enterprise V:
HK$ 1.64B ($ 209.89M)
Volume:
1.27M
Avg Vol (2M):
994.16K
Also Trade In:
Volume:
1.27M
At Loss
Avg Vol (2M):
994.16K

Business Description

Description
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America.
Name Current Vs Industry Vs History
Cash-To-Debt 21.71
Equity-to-Asset 0.8
Debt-to-Equity 0.05
Debt-to-EBITDA -0.12
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 15.3
3-Year EPS without NRI Growth Rate -27.3
3-Year FCF Growth Rate -11.5

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 66.85
9-Day RSI 63.55
14-Day RSI 59.48
6-1 Month Momentum % -48.93
12-1 Month Momentum % -51.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.55
Quick Ratio 9.54
Cash Ratio 9.43

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.5
Shareholder Yield % 4.34

Profitability Rank

Name Current Vs Industry Vs History
ROE % -34.34
ROA % -29.05
ROIC % -128.05
ROC (Joel Greenblatt) % -183.61
ROCE % -31.75

Financials (Next Earnings Date:2024-09-19 Est.)

HKSE:02171's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

CARsgen Therapeutics Holdings Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$)
EPS (TTM) (HK$) -1.465
Beta 0
Volatility % 98.65
14-Day RSI 59.48
14-Day ATR (HK$) 0.400842
20-Day SMA (HK$) 5.452
12-1 Month Momentum % -51.03
52-Week Range (HK$) 3.73 - 12
Shares Outstanding (Mil) 575.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CARsgen Therapeutics Holdings Ltd Filings

Filing Date Document Date Form
No Filing Data

CARsgen Therapeutics Holdings Ltd Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

CARsgen Therapeutics Holdings Ltd Frequently Asked Questions

What is CARsgen Therapeutics Holdings Ltd(HKSE:02171)'s stock price today?
The current price of HKSE:02171 is HK$6.10. The 52 week high of HKSE:02171 is HK$12.00 and 52 week low is HK$3.73.
When is next earnings date of CARsgen Therapeutics Holdings Ltd(HKSE:02171)?
The next earnings date of CARsgen Therapeutics Holdings Ltd(HKSE:02171) is 2024-09-19 Est..
Does CARsgen Therapeutics Holdings Ltd(HKSE:02171) pay dividends? If so, how much?
CARsgen Therapeutics Holdings Ltd(HKSE:02171) does not pay dividend.

Press Release

Subject Date
No Press Release